Year: 2015
Session type: Parallel sessions, Proffered paper sessions
Jeremy S Whelan1,Matthew R Sydes10,Stefan S Bielack2,Sigbjørn Smeland4,Neyssa Marina3,Gordana Jovic10,Trude Butterfass-Bahloul5,Gabriele Calaminus6,Mikael Eriksson7,Hans Gelderblom8,Richard G Gordlick9,Pancras Hogendoorn8,Jane Hook10,Leo Kager11,Mark D Krailo12,Thomas Khüne13,R Lor Randall14,Kirsten Sundby Hall4,Lisa A Teot15,Mark Bernstein16
1University College Hospital, London, UK,2Olgahospital, Klinikum Stuttgart, Stuttgart, Germany,3Stanford University School of Medicine, Palo Alto, CA, USA,4Oslo University Hospital, The Norwegian Radium Hospital, Scandinavian Sarcoma Group, Oslo, Norway,5Center for Clinical Trials, University of Münster,, Münster, Germany,6University Hospital of Münster, Münster, Germany,7Skane University Hospital and Lund University, Lund, Sweden,8Leiden University Medical Center, Leiden, The Netherlands,9The Children’s Hospital, Bronx, NY, USA,10MRC Clinical Trials Unit at UCL, London, UK,11St Anna Children’s Hospital, Vienna, Austria,12Childrens Oncology Group, Arcadia, CA, USA,13University Children’s Hospital Basel, Basel, Switzerland,14Huntsman Cancer Inst, Salt Lake City, UT, USA,15Children’s Hospital Boston, Boston, MA, USA,16IWK Health Centre, Halifax, NS, Canada